Suchergebnisse - "Kanesvaran, R"

PubPharm (18)

1

Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries

enthalten in: ESMO open | 2022

von Soo, R. | Mery, L. | Bardot, A. | +13

2

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

enthalten in: ESMO open | 2022

von Kanesvaran, R. | Castro, E. | Wong, A. | +21

3

Current standards and practice changing studies in genitourinary (GU) cancers-a review of studies in localized/early GU cancers

enthalten in: ESMO open | 2022

von Tan, W. | Kanesvaran, R.

4

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

enthalten in: ESMO open | 2021

von Kanesvaran, R. | Porta, C. | Wong, A. | +21

5

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer : Vaccinate. Monitor. Educate

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Garassino, M. | Vyas, M. | de Vries, E. | +4

6

Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)

enthalten in: BMC cancer | 2020

von Kkf, C. | Mitchell, S. | Chan, N. | +3

7

Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)

enthalten in: BMC cancer | 2020

von KKF, C. | Mitchell, S. | Chan, N. | +3

8

Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)

enthalten in: BMC cancer | 2020

von KKF, C. | Mitchell, S. | Chan, N. | +3

9

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

10

Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma : results from the International Metastatic Renal Cell Carcinoma Database Consortium

enthalten in: Current oncology (Toronto, Ont.) | 2019

von Stukalin, I. | Wells, J. | Graham, J. | +17